{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:48:38Z","timestamp":1768009718586,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190104"],"award-info":[{"award-number":["RR190104"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["K23 HL159271"],"award-info":[{"award-number":["K23 HL159271"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1OT2-OD032581"],"award-info":[{"award-number":["1OT2-OD032581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021037","name":"Taipei City Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.015","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T07:14:37Z","timestamp":1692342877000},"page":"685.e1-685.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-8892","authenticated-orcid":false,"given":"Shengling","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Bhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-614X","authenticated-orcid":false,"given":"Danielle","family":"Guffey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rock Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3457-8473","authenticated-orcid":false,"given":"Mahrukh","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I.","family":"Amos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta R.","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Sartain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-2309","authenticated-orcid":false,"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.015_bib0001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2023.08.015_bib0002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/bjh.16457","article-title":"Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy","volume":"189","author":"Epperla","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.08.015_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.01.009","article-title":"Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"28","author":"Van Benschoten","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.015_bib0004","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy","volume":"120","author":"Gavriilaki","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtct.2023.08.015_bib0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.015_bib0006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jpm11060467","article-title":"Thrombotic microangiopathy: multi-institutional review of pediatric patients who underwent HSCT","volume":"11","author":"Ramgopal","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jtct.2023.08.015_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.08.015_bib0008","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/bloodadvances.2019001242","article-title":"Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort","volume":"4","author":"Schoettler","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.08.015_bib0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.015_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2020.12.010","article-title":"Prognostic biomarkers for thrombotic microangiopathy after acute graft-versus-host disease: a nested case-control study","volume":"27","author":"Li","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.08.015_bib0011","article-title":"Validation of early increase in complement activation marker sC5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation","volume":"7","author":"Mez\u00f6","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2023.08.015_bib0012","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1182\/blood-2022-163213","article-title":"Complement activation is associated with endothelial damage in hematopoietic stem cell transplant associated-thrombotic microangiopathy","volume":"140","author":"Jacobi","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.08.015_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.695037","article-title":"Early elevation of complement factor Ba is a predictive biomarker for transplant-associated thrombotic microangiopathy","volume":"12","author":"Okamura","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.08.015_bib0014","doi-asserted-by":"crossref","first-page":"e28070","DOI":"10.1002\/pbc.28070","article-title":"The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy","volume":"67","author":"Sartain","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.08.015_bib0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2023.08.015_bib0016","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bbmt.2018.10.015","article-title":"Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal","volume":"25","author":"Li","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.015_bib0017","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00467-007-0616-x","article-title":"The thrombotic microangiopathies","volume":"23","author":"Copelovitch","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jtct.2023.08.015_bib0018","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy: a case series","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.015_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1704601","article-title":"Automated measurement of schistocytes after bone marrow transplantation","volume":"34","author":"Lesesve","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.015_bib0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1751-553X.2010.01292.x","article-title":"Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation","volume":"33","author":"Lesesve","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtct.2023.08.015_bib0021","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.015_bib0022","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.08.015_bib0023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:15Z","timestamp":1763003415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723014720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723014720"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}